Mutation-Specific and Common Phosphotyrosine Signatures of KRAS G12D and G13D Alleles-Reference-Cited by-同舟云学术

Mutation-Specific and Common Phosphotyrosine Signatures of KRAS G12D and G13D Alleles

Published:2020-09-28 Issue:1 Volume:20 Page:670-683
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Tahir Raiha¹²,Renuse Santosh³,Udainiya Savita⁴⁵⁶,Madugundu Anil K.³⁴⁵,Cutler Jevon A.³⁷,Nirujogi Raja Sekhar³,Na Chan Hyun⁸,Xu Yaoyu²³,Wu Xinyan²³,Pandey Akhilesh²³⁵⁶^ORCID

Affiliation:

1. Biochemistry, Cellular and Molecular Biology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States

2. Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States

3. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States

4. Institute of Bioinformatics, International Technology Park, Bangalore 560066, India

5. Manipal Academy of Higher Education (MAHE), Manipal 576104, Karnataka, India

6. Departments of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States

7. Pre-Doctoral Training Program in Human Genetics, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States

8. Department of Neurology, Institute of Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.0c00587

Reference63 articles.

1. Drugging the undruggable RAS: Mission Possible?

2. KRAS Alleles: The Devil Is in the Detail

3. RAS Proteins and Their Regulators in Human Disease

4. Oncogenic Activation of the RAS/RAF Signaling Pathway Impairs the Response of Metastatic Colorectal Cancers to Anti–Epidermal Growth Factor Receptor Antibody Therapies

5. Understanding the Predictive Role of K-ras for Epidermal Growth Factor Receptor–Targeted Therapies in Colorectal Cancer

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of KRAS mutation on the tumor microenvironment in colorectal cancer;International Journal of Biological Sciences;2024

2. NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease;Journal of Biological Chemistry;2023-08

3. Proteomics of post-translational modifications in colorectal cancer: Discovery of new biomarkers;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2022-07

4. Comprehensive Molecular Profiling of Colorectal Cancer With Situs Inversus Totalis by Next-Generation Sequencing;Frontiers in Oncology;2022-04-20

5. Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner;Cancers;2022-03-23